A government minister said earlier the AstraZeneca/Oxford vaccine had been given the green light on Friday, paving the way for a huge immunisation campaign in the world's second most populous country.
Dr Guleria further addressed apprehensions about the safety of the vaccine considering that it was tested and introduced in a short span of time, saying, "Safety is the most important factor and all standard precautions have been followed in the past for the approval of the vaccine", adding that the vaccine in India would be as effective as those developed by other countries. It is also not clear under which provisions of the extant law the SEC has recommended for grant of REU approval and in "clinical trial mode" at that, AIDAN said.
"Bharat Biotech has developed a Whole Virion Inactivated Corona Virus Vaccine (Covaxin) in collaboration with ICMR and NIV (Pune), from where they received the virus seed strains". China's US$62 billion belt and road project in Pakistan risks becoming corridor to nowhereRepresentatives from the two countries" foreign ministries met this week in Urumqi, Xinjiang and agreed to push ahead on CPEC cooperation to boost economic growth."CPEC is not going away and neither is the China-Pakistan relationship", said Claude Rakisits, a professor of worldwide relations at Australian National University."It's a relationship of convenience that has worked well for both sides.
Out of 1.3 billion people, Bhushan said 300 million people from priority groups would be vaccinated first.
Although Pfizer's shot was the first to be rolled out following the publication of full Phase III trial data, Russian Federation and China have been inoculating their citizens for months with several different vaccines still undergoing late-stage trials.
"The publication of phase II trial data is undergoing the peer review process".
Co-Win or COVID-19 Vaccine Intelligence Network is an upgraded version of the eVIN (Electronic Vaccine Intelligence Network) which will be used by the Health Ministry during the vaccination drive in India. The approval, he said, "accelerates the road to a healthier and COVID-free nation".
In a series of tweets, Prime Minister Narendra Modi said the development marked a "decisive turning point to strengthen a spirited fight".
Bharat Biotech on Saturday announced successful recruitment of 23,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for phase-III clinical trial of its coronavirus vaccine "Covaxin" across multiple sites in India.
Footballers were also among those caught breaking the rules, with Tottenham's Erik Lamela, Sergio Reguilon and Giovani Lo Celso to be disciplined after a picture emerged of them attending a large party.
Britain and Argentina this week authorised the AstraZeneca vaccine while the World Health Organization on Thursday granted emergency validation to the rival Pfizer-BioNTech vaccine. It has developed vaccines for influenza H1N1, Rotavirus, Japanese Encephalitis, Rabies, Chikungunya, Zika and the world's first tetanus-toxoid conjugated vaccine for Typhoid.
- Ontario hits record high 3328 new COVID-19 cases
- Veteran US Talk show host Larry King hospitalized with COVID-19
- Can Atleti snatch La Liga's title away from Barca?
- Minimum wage in Montana will increase on January 1st
- India approves vaccines as nations fight virus resurgence
- British PM's father plans to seek French citizenship
- India approves AstraZeneca Covid vaccine
- Hospital worker deliberately destroys 500 doses of Moderna Covid vaccine, Report
- VP Pence: Election results are not up to me
- World Health Organization lists Pfizer vaccine for emergency use